tiprankstipranks
Trending News
More News >
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market

Crispr Therapeutics AG (CRSP) Technical Analysis

Compare
9,179 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is -0.70, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 37.12, while Crispr Therapeutics AG’s (CRSP) share price is $34.25, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 38.70, while Crispr Therapeutics AG’s (CRSP) share price is $34.25, making it a Sell.

Crispr Therapeutics AG (CRSP) Pivot Points

May 08, 2025, 09:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.86
30.45
31.80
34.39
35.74
38.33
39.68
Fibonacci
30.45
31.95
32.88
34.39
35.89
36.82
38.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

May 08, 2025, 09:47 AM
Period
Simple
Exponential
MA5
36.20Sell
35.65Sell
MA10
37.23Sell
36.56Sell
MA20
37.48Sell
37.12Sell
MA50
38.99Sell
38.70Sell
MA100
40.78Sell
41.07Sell
MA200
44.87Sell
45.14Sell
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 36.56, while Crispr Therapeutics AG’s (CRSP) share price is $34.25, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 41.07, while Crispr Therapeutics AG’s (CRSP) share price is $34.25, making it a Sell.
Crispr Therapeutics AG’s (CRSP) stock price is $34.25 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 38.99, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $34.25 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 40.78, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $34.25 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 44.87, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

May 08, 2025, 09:47 AM
Name
Value
Implied Action
RSI (14)
39.65
Neutral
STOCH (9,6)
18.20
Buy
STOCHRSI (14)
16.98
Buy
MACD (12,26)
-0.70
Buy
ADX (14)
16.33
Buy
Williams %R
-84.16
Buy
CCI (14)
-160.17
Buy
ATR (14)
2.19
-
Ultimate Oscillator
38.83
Neutral
ROC
-9.34
Sell
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 39.65, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 16.33, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is -160.17, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is -9.34, creating a Sell signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Sell.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 39.65, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is -0.70, which suggests CRSP is a Buy.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 36.20, which suggests CRSP is a Sell.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 37.48, which suggests CRSP is a Sell.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 38.99, which suggests CRSP is a Sell.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 44.87, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -84.16, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is -160.17, which suggests CRSP is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis